4 Firms Rep $193M In Biotech, Life Sciences-Focused IPOs
A pair of immuno-oncology and uterine health companies began trading on the Nasdaq on Friday following initial public offerings raising a combined $192.6 million that were guided by four law firms,...To view the full article, register now.
Already a subscriber? Click here to view full article